Rephonic
Artwork for BioSpace

BioSpace

BioSpace
FDA
Clinical Trials
Eli Lilly
Novo Nordisk
Pfizer
Glp-1
Gene Therapy
Drug Development
Artificial Intelligence
Women's Health
Johnson & Johnson
Merck
Biopharma
China
Duchenne Muscular Dystrophy
Sarepta
Job Market
Astrazeneca
Women In Clinical Trials
Biopharma Industry

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.

PublishesDailyEpisodes236Founded3 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BioSpace

Latest Episodes

In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why tr... more

At the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this past weekend, packed plenary sessions from Revolution Medicines and Summit Therapeutics’ Chinese partner Akeso stole the show. For RevMed, analysts anticipate a potent... more

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partn... more

Eli Lilly has been as acquisitive as ever, striking five new deals in the past week alone. On Tuesday, the company dove into the deep end of vaccine development with three separate buys in the space. Outside of vaccines, Lilly scooped up preclinical ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Odd Lots
Odd LotsBloomberg

Recent Guests

Thierry Laugel
Managing Partner at Kurma Partners
Kurma Partners
Episode: France’s biotech ecosystem: science, capital and scale
Ksenija Pavletic
Partner and Chief Commercial Officer at Jeito Capital
Jeito Capital
Episode: France’s biotech ecosystem: science, capital and scale
Regina Hodits
Managing Director at Angelini Ventures
Angelini Ventures
Episode: Inside Germany’s biotech capital infrastructure and innovation engine
Sofia Ioannidou
VC Partner at Andera Life Sciences
Andera Life Sciences
Episode: Inside Germany’s biotech capital infrastructure and innovation engine
John Ellis
CEO and co-founder of Trenchant Bio
Trenchant Bio
Episode: From MSCs to iPSCs: building the cell therapy future
Jonas Hallén
Co-Founder and Chief Medical Officer of Calluna Pharma
Calluna Pharma
Episode: Fibrosis, IPF and the search for better therapies
Georg Beiske
CEO of Tribune Therapeutics
Tribune Therapeutics
Episode: Fibrosis, IPF and the search for better therapies
Kef Rourouette
CEO of QurAlis
QurAlis
Episode: Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening
Yaniv Sneor
Founder of Mid Atlantic Bio Angels
Mid Atlantic Bio Angels
Episode: What makes life science angel investment work?

Hosts

Jennifer Smith-Parker
Director of Insights at BioSpace; host on multiple BioSpace programs; senior editor and industry commentator
Jeff Axt
Host and Managing Editor; leads BioSpace weekly and newsletters
Annali Armstrong
Senior Editor; BioSpace; weekly BioPharm Executive and related newsletters
Annaleigh Armstrong
Senior Editor; BioSpace; BioPharm Executive and related newsletters
Heather McKenzie
Senior Editor; host of BioSpace weekly discussions; subject matter expert

Reviews

4.7 out of 5 stars from 32 ratings
  • informative and lively

    Love the podcast. The roundtable discussions are engaging, informative, and lively. The information shared helps keep me current in the biopharma industry.

    Apple Podcasts
    5
    AudraStar
    United States8 months ago
  • Great content, the sound quality needs to improve

    The topics discussed are relevant and interesting. The sound quality needs to improve, especially normalizing the volume of the different speakers and using better microphones to avoid saturation.

    Apple Podcasts
    4
    MarcoMtt
    United Statesa year ago
  • Love this podcast

    Love this pod, keep up the good work!

    Apple Podcasts
    5
    Ddxbsbabs
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

- Frequent guests and timely industry coverage keep the content relevant and valuable.
- Sound quality and microphone consistency could improve for a better listening experience.
- The roundtable format is engaging and informative for staying current in biopharma.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

France’s biotech ecosystem: science, capital and scale
Q: How is Jeito addressing the capital gap in Europe?
By deploying a large fund and aiming to provide substantial capital (up to 150 million euros per company in development) to de-risk and accelerate clinical progress, thereby bridging the gap between early science and later-stage financing.
France’s biotech ecosystem: science, capital and scale
Q: What does France still need to do to turn more academic innovation into investible biotech?
Enhance entrepreneurial energy and scale, speed up tech transfer, and expand patient, risk-tolerant capital to move early-stage assets toward clinical development and eventual commercial potential.
Inside Germany’s biotech capital infrastructure and innovation engine
Q: What makes Germany an important part of Europe's innovation engine right now?
Germany has a deep tradition of industry and strong infrastructure, including clinical trials and manufacturing capacities, coupled with excellent science from universities and research institutes; cross-border collaboration and a robust local funding network help translate science into companies that can scale regionally and globally.
From MSCs to iPSCs: building the cell therapy future
Q: I'm just curious here with so much potential, but there's challenges. It definitely sounds like to getting to this point. So I'm curious as to how competitive are MSCs and IPSCs today from a manufacturing and a scalability standpoint?
The guests acknowledge the significant manufacturing challenges but stress the importance of scalable, consistent production, including transitioning from bench to clinic to commercial, and the potential of iPSC-derived lines to standardize production.
From MSCs to iPSCs: building the cell therapy future
Q: So for shorthand, MSCs and iPSCs. So I think to start off, if you can introduce yourselves, that would be great. Miguel, why don't we start with you?
Miguel introduces his background and emphasizes MSCs as a cornerstone of cell and gene therapy, highlighting regulatory recognition and broad potential, with iPSCs seen as a future platform to generate any needed cell types.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioSpace

What is BioSpace about and what kind of topics does it cover?

A biopharma-focused program that covers science, funding, policy, and industry strategy through roundtable discussions, guest interviews, and market updates. Episodes frequently tackle European and U.S. funding landscapes, manufacturing and commercialization hurdles for cell therapies and fibrosis programs, regulatory shifts, and pharma deal cycles. Noteworthy traits include a strong emphasis on European ecosystem building, practical insights from investors and operators, and ongoing debates about how policy, pricing, and manufacturing scale shape biotech growth. The show is helpful for listeners who want a clear read on what moves the industry, investors, and policymakers are making, and how those moves impact company building and investme... more

Where can I find podcast stats for BioSpace?

Rephonic provides a wide range of podcast stats for BioSpace. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioSpace and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioSpace get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioSpace, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioSpace?

Rephonic provides comprehensive predictive audience data for BioSpace, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioSpace have?

To see how many followers or subscribers BioSpace has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioSpace?

These podcasts share a similar audience with BioSpace:

1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. The Long Run with Luke Timmerman
5. Odd Lots

How many episodes of BioSpace are there?

BioSpace launched 3 years ago and published 236 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioSpace?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioSpace?

Rephonic pulls ratings and reviews for BioSpace from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioSpace?

Rephonic provides full transcripts for episodes of BioSpace. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioSpace?

Recent guests on BioSpace include:

1. Thierry Laugel
2. Ksenija Pavletic
3. Regina Hodits
4. Sofia Ioannidou
5. John Ellis
6. Jonas Hallén
7. Georg Beiske
8. Kef Rourouette

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days